United Therapeutics Corporation
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $705.1M | $1.02B | $831.8M | $397.7M | $284.3M | $159.4M | $168.0M | $252.2M |
| Accounts Receivable | $297.1M | $214.5M | $192.8M | $162.3M | $126.3M | $116.6M | $88.7M | $73.7M |
| Inventory | $107.9M | $100.0M | $81.3M | $66.9M | $47.8M | $37.3M | $46.0M | $35.5M |
| Total Current Assets | $1.45B | $1.42B | $1.28B | $957.6M | $914.4M | $668.5M | $562.5M | $764.5M |
| Property, Plant & Equipment | $545.7M | $489.3M | $495.8M | $478.4M | $465.0M | $453.7M | $366.0M | $306.0M |
| Goodwill | $13.7M | $10.3M | $10.3M | $10.3M | $10.7M | $10.5M | $8.1M | $2.5M |
| Intangible Assets (Excl. Goodwill) | — | — | $2.6M | $3.7M | $3.4M | $5.9M | — | — |
| Total Assets | $2.88B | $2.33B | $2.18B | $1.88B | $2.09B | $1.63B | $1.52B | $1.43B |
| Liabilities | ||||||||
| Accounts Payable | $8.4M | $8.1M | $7.5M | $7.0M | $6.7M | $10.2M | $47.3M | $16.1M |
| Total Current Liabilities | $444.7M | $332.5M | $440.7M | $504.3M | $687.7M | $176.8M | $212.6M | $428.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $758.4M | $463.4M | $584.7M | $618.8M | $783.3M | $531.7M | $558.7M | $536.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $2.85B | $2.43B | $1.72B | $1.07B | $728.0M | $553.5M | $249.0M | $31.2M |
| Total Stockholders' Equity | $2.10B | $1.85B | $1.59B | $1.24B | $1.26B | $1.08B | $948.5M | $883.9M |